France · 
Who invested in Egle Therapeutics?
Egle Therapeutics's investors include Bpifrance, European Commission and EQT Life Sciences.
France · Funded startup
Who invested in Egle Therapeutics
Funding summaryUpdated 26 Oct 2026
$9.4Mraised across 1 round since 2026, from 1 source
- Latest round
- Grant, $9.4MMar 2026
- Investors
- 3
The rounds
- Mar 2026
Founders and team
From Egle Therapeutics's own website: 8 on the team.
- John CelebiChief Executive Officer
- Laurenz GovaertsVice President at EQT-LSP
- Bart De LeeuwChief Financial Officer
- Florence WastelinHead of Program Management
- Elisa El NouchiAssociate at BPI-Innobio2
- Felice Verduyn-van WeegenPartner in the EQT Life Sciences team
- Michel DetheuxChairman
- Simon CooperNon Executive Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Egle Therapeutics
How much has Egle Therapeutics raised?
Egle Therapeutics has raised $9.4M across 1 round since 2026.
When did Egle Therapeutics last raise?
Egle Therapeutics's most recent round was a Grant of $9.4M in Mar 2026.
What was Egle Therapeutics's biggest round?
Its most recent round, $9.4M in Mar 2026, is also its largest on record.
Who backed Egle Therapeutics first?
Egle Therapeutics's first round on record, in Mar 2026, was backed by Bpifrance, European Commission and EQT Life Sciences.
What stage is Egle Therapeutics at?
Egle Therapeutics's latest named round is a Grant, in Mar 2026.
Where is Egle Therapeutics based?
Egle Therapeutics is based in France.
Companies like Egle Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.